Request for Industry Review and Comments on Draft Statement of Work (SOW) PPV 2028 Amendment to Extend Response Date from July 2 to July 10, 2026 11:00 AM CT. Department of Veterans Affairs Request for Industry Review and Comments on Draft Statement of Work (SOW) Pharmaceutical Prime Vendor (PPV) 2028 The Department of Veterans Affairs (VA) is seeking industry review and feedback on the attached DRAFT Statement of Work (SOW), Definitions and Distribution Fee Categories for the Pharmaceutical Prime Vendor 2028 acquisition. This early engagement is intended to ensure the final SOW is clear, comprehensive and structured to support effective competition from qualified vendors. Industry is invited to provide input including, but not limited to: Identification of unclear, conflicting, or ambiguous requirements Comments on technical or operational requirements that may affect performance Suggestions related to distribution operations, inventory management, reporting, data exchange, or order fulfillment processes Noted risks, barriers, or areas where additional definition would be beneficial Suggestions to improve efficiency, or alignment with industry best practices Industry feedback at this stage helps the VA refine requirements and improve acquisition outcomes. The VA may contact respondents for clarification of submitted comments. Feedback received may be considered in the development of subsequent SOW revisions and acquisition documentation. Participation in this review is voluntary and is not a prerequisite for participation in any future solicitation. Submission Instructions: Provide feedback no later than 11AM Central July 10, 2026 Send responses via email to Karen.Ade@va.gov Include the following in your submission: Company Name Point of contact name, phone and email UEI and CAGE Code Socioeconomic designation(s), if applicable Important Notes: This announcement is not a solicitation and does not obligate the Government to issue a solicitation or award. No contract will be awarded from this notice Participation in this review (or lack thereof) does not preclude any vendor from submitting a proposal to the future PPV 2028 solicitation. All feedback will be used for market research and SOW refinement purposes only. The Government will not reimburse any costs associated with providing comments or participating in any related activities. The VA appreciates industry s time and expertise in supporting the development of a strong, effective SOW for the PPV 2028 program. The VA appreciates industry s participation in helping to shape a clear and effective SOW for the PPV 2028 program, which supports delivery of pharmaceutical products to VA medical centers nationwide.